Clinical Trial: Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study

U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975085) titled 'Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study' on May 07.

Brief Summary: The Understanding and Addressing Rejection of Personalized Cancer Risk Information study is a longitudinal study conducted to understand the nature of phenomenon of personalized cancer risk rejection in the context of mammography screening.

Study Start Date: April 16

Study Type: INTERVENTIONAL

Condition: Breast Cancer Female

Intervention: BEHAVIORAL: Presentation of a personal breast cancer risk estimate

Participants answer questions that are used to calculate their personal breast c...